A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enhances T cell immunogenicity and may turn non-inflam...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6a4885a11bbe41c6aef5c595a4d1525a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6a4885a11bbe41c6aef5c595a4d1525a2021-12-02T19:10:37ZA modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity10.1038/s41467-021-25506-62041-1723https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25506-6https://doaj.org/toc/2041-1723Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enhances T cell immunogenicity and may turn non-inflamed tumours proinflammatory and less resistant to checkpoint blockade therapy.Krishna DasElodie BelnoueMatteo RossiTamara HoferSarah DanklmaierTobias NoldenLiesa-Marie SchreiberKatharina AngererJanine KimpelSandra HoeglerBart SpiesschaertLukas KennerDorothee von LaerKnut ElbersMadiha DerouaziGuido WollmannNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Krishna Das Elodie Belnoue Matteo Rossi Tamara Hofer Sarah Danklmaier Tobias Nolden Liesa-Marie Schreiber Katharina Angerer Janine Kimpel Sandra Hoegler Bart Spiesschaert Lukas Kenner Dorothee von Laer Knut Elbers Madiha Derouazi Guido Wollmann A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
description |
Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enhances T cell immunogenicity and may turn non-inflamed tumours proinflammatory and less resistant to checkpoint blockade therapy. |
format |
article |
author |
Krishna Das Elodie Belnoue Matteo Rossi Tamara Hofer Sarah Danklmaier Tobias Nolden Liesa-Marie Schreiber Katharina Angerer Janine Kimpel Sandra Hoegler Bart Spiesschaert Lukas Kenner Dorothee von Laer Knut Elbers Madiha Derouazi Guido Wollmann |
author_facet |
Krishna Das Elodie Belnoue Matteo Rossi Tamara Hofer Sarah Danklmaier Tobias Nolden Liesa-Marie Schreiber Katharina Angerer Janine Kimpel Sandra Hoegler Bart Spiesschaert Lukas Kenner Dorothee von Laer Knut Elbers Madiha Derouazi Guido Wollmann |
author_sort |
Krishna Das |
title |
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
title_short |
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
title_full |
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
title_fullStr |
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
title_full_unstemmed |
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
title_sort |
modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a |
work_keys_str_mv |
AT krishnadas amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT elodiebelnoue amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT matteorossi amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT tamarahofer amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT sarahdanklmaier amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT tobiasnolden amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT liesamarieschreiber amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT katharinaangerer amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT janinekimpel amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT sandrahoegler amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT bartspiesschaert amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT lukaskenner amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT dorotheevonlaer amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT knutelbers amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT madihaderouazi amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT guidowollmann amodularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT krishnadas modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT elodiebelnoue modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT matteorossi modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT tamarahofer modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT sarahdanklmaier modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT tobiasnolden modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT liesamarieschreiber modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT katharinaangerer modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT janinekimpel modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT sandrahoegler modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT bartspiesschaert modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT lukaskenner modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT dorotheevonlaer modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT knutelbers modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT madihaderouazi modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity AT guidowollmann modularselfadjuvantingcancervaccinecombinedwithanoncolyticvaccineinducespotentantitumorimmunity |
_version_ |
1718377091567714304 |